Applied Genetic Technologies Corporation(AGTC)

Description: Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. The company also completed preclinical proof-of-concept studies, and Phase I and Phase II clinical trials of a treatment for alpha-1 antitrypsin deficiency, an inherited orphan lung disease. In addition, it has proof-of-concept programs for other eye diseases, such as leber congenital amaurosis (type 2), and wet form of age-related macular degeneration. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.

---

Keywords: Biotechnology Disease Ophthalmology Gene Therapy Eye Vision Macular Degeneration Eye Diseases Age Related Macular Degeneration Antitrypsin Deficiency Retinitis Pigmentosa Retinitis Gene Therapy Products Leber Congenital Amaurosis Retinoschisis X Linked Retinitis Pigmentosa

---

Home Page: agtc.com

AGTC Technical Analysis

14193 NW 119th Terrace
Alachua, FL 32615
United States
Phone: 386 462 2204

---

Officers

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)